عنوان
پدید آورنده
موضوع
رده
R1
R1
کتابخانه
محل استقرار
3319406973
9783319406978
3319406965
9783319406961
b433280
Drugs during pregnancy :
[Book]
methodological aspects /
Bengt Källén
1 online resource (120 pages)
11: Timing of;Drug Use and;Effects on;the;Embryo or Fetus
Includes bibliographical references
Preface; Contents; Abbreviations; 1: Introduction; 2: The "Alert Clinician"; 2.1 Thalidomide; 2.2 Anticonvulsants; 2.3 Warfarin; 2.4 Drugs for;Thyrotoxicosis; 2.5 Retinoids; 2.6 Mycophenolate Mofetil; References; 3: Animal Experiments and;Adverse Drug Reaction Reports; 3.1 Animal Experiments; 3.2 Adverse Drug Reaction Reports; References; 4: Some Epidemiological Principles; 4.1 Population Studies; 4.2 Case-Control Studies; 4.3 Cohort Studies; 4.4 Comparison Between Case-Control and;Cohort Studies; 4.5 Nested Case-Control Studies; 4.6 The Sibling Approach; References
5: Pregnancy Outcomes with;the;Exception of;Congenital Malformations5.1 Maternal Pregnancy Complications; 5.1.1 Preeclampsia; 5.1.2 Placenta Previa; 5.1.3 Placenta Abruption; 5.1.4 Other Pregnancy Complications; 5.2 Spontaneous Abortion; 5.3 Stillbirth and;Infant Death; 5.4 Gestational Duration and;Birth Weight; 5.5 Intrauterine Growth; 5.6 Other Body Dimensions; 5.7 Perinatal Morbidity; 5.8 Long-Term Effects; References; 6: Congenital Malformations; 6.1 Definition; 6.2 Major and;Minor Malformations; 6.3 Single and;Multiple Malformations; 6.4 Causes of;Congenital Malformations
6.4.1 Genetics6.4.2 Chromosome Anomalies; 6.4.3 External Factors; 6.5 Sources of;Information on;Malformations; 6.6 Prenatal Diagnosis and;Induced Abortion; 6.7 Grouping of;Congenital Malformations; References; 7: Identification of;Maternal Use of;Drugs; 7.1 Questionnaires or Interviews in;a;Case-Control Setting; 7.2 Prospective Randomized Studies; 7.3 Teratology Information Services (TIS); 7.4 Prospective Studies of;Pregnant Populations; 7.5 Pregnancy Registers; 7.6 The Swedish Medical Birth Register; 7.7 Prescription Registers
7.8 The Effect of;Errors in;Drug Exposure Ascertainment7.9 Information on;Dosage of;Drugs Used; References; 8: The Problem of;Confounding; 8.1 Mediating Factors Should Not Be;Adjusted for; 8.2 Some Common and;Sometimes Important Confounders; 8.2.1 Year of;Birth; 8.2.2 Maternal Age; 8.2.3 Parity and;Gravidity; 8.2.4 Smoking; 8.2.5 Use of;Alcohol; 8.2.6 Overweight and;Obesity; 8.2.7 Subfertility; 8.2.8 Race/Nationality; 8.2.9 Socioeconomic Level; 8.2.10 Geography; 8.2.11 Previous Reproductive History; 8.2.12 Infant Sex; 8.2.13 Concomitant Maternal Disease and;Drug Use
8.2.14 Confounding by Indication8.3 Interaction Between Confounders; 8.4 Residual Confounding; References; 9: Statistics for;Dummies; 9.1 Risk Estimates; 9.2 Is the;Odds Ratio or Risk Ratio Statistically Significant?; 9.3 The Confidence Interval; 9.4 Expected Numbers; 9.5 Dealing with;Confounders; 9.5.1 Matching; 9.5.2 Adjustment; 9.6 Survival Analysis; 9.7 Power Analysis; 9.8 The p-value and;Mass Significance; References; 10: Lumping or Splitting?; 10.1 Lumping or Splitting of;Drug Exposures; 10.2 Lumping or Splitting of;Outcomes; References
0
8
8
8
8
Drugs During Pregnancy : Methodological Aspects
9783319406961
Obstetrical pharmacology.
Pregnant women-- Drug use.
HEA-- 012000
HEA-- 020000
MED-- 004000
MED-- 029000
MED-- 040000
MED-- 092000
MED-- 101000
MED-- 109000
610
618
.
2061
23
R1
RG528
Källén, Bengt
Ohio Library and Information Network.
20161014100407.3
rda
مطالعه متن کتاب [Book]
Y
